Tag: VIVO.V

CannabisNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) Enters Technology and Research Partnership with CB2 Insights Inc. (CSE: CBII) (OTCQB: CBIIF)

VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF), an Ontario-based cannabis company recognized for its premium products and services, has entered into a technology and multi-phase research agreement with CB2 Insights Inc. (CSE: CBII) (OTCQB: CBIIF) (“CB2”), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the medical cannabis community. Under the agreement, CB2 will assist in the development of VIVO’s global medical product development strategy. CB2 will integrate its Clinical Data Management Software (“CDMS”) and Electronic Data Capture (“EDC”) tools to establish a better understanding of VIVO’s current medical patient registry, and the companies will collaborate on a comprehensive research strategy to validate the safety and efficacy of current products. “CB2’s global experience in clinical research and technology will enable VIVO to enhance our understanding of Canadian medical patients. This will facilitate our uncovering of new ways to meet the expectations of our current patients and will help inform our international growth plans,” VIVO CEO Barry Fishman said in the news release. “At VIVO, our purpose is to help patients achieve a positive quality of life with cannabis. We look forward to utilizing our partnership with CB2 to further bring real world evidence to the medical cannabis industry.”

To view the full press release, visit http://cnw.fm/C6Pwd

About VIVO Cannabis(TM)

VIVO, based in Napanee, Ontario, is recognized for trusted, high-quality products and services. It holds production and sales licenses from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical(TM), FIRESIDE(TM), Canna Farms(TM) and Lumina(TM). In August 2018, VIVO acquired Canna Farms, a premium cannabis company based in Hope, British Columbia. Canna Farms was B.C.’s first Licensed Producer and has several years of craft cultivation experience and expertise, as well as a significant patient base and positive cash flow. The company is significantly expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, including Germany and Australia. VIVO also operates Harvest Medicine, a patient-centric and highly scalable network of specialty medical cannabis clinics as well as a free telemedicine service. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally. For more information, visit the company’s website at www.VivoCannabis.com.

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://cnw.fm/VIVO

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Connecticut Lawmakers Approve More Medical Marijuana Qualifying Conditions

The lawmakers in Connecticut have allowed more medical marijuana qualifying conditions. On Tuesday, the General Assembly Regulations Review Committee added five qualifying conditions for adults. Two of the five conditions are intractable neuropathic pain and Tourette syndrome. Patients under the age of 18 with the two ailments were are also approved to use medical marijuana.

In a written statement, Michelle H. Seagull, the Consumer Protection Commissioner, thanked the members of the Regulations Review Committee and the Board of Physicians for the addition of the qualifying conditions. She further said that it is good to know that medical marijuana will be available to more patients who are suffering from debilitating diseases. Seagull is also looking forward to working on the program.

The regulations will be submitted to the Secretary of State’s office to be finalized, and then posted online.

In addition to the two approved conditions, the General Assembly Regulations Review Committee also approved interstitial cystitis, median arcuate ligament syndrome and vulvodynia, and vulva burning. Chronic pain was approved by the Medical Marijuana Program Board as a qualifying condition last month; however, the Regulations Review Committee did not vote for it on Tuesday.

In Connecticut, 37,080 patients are participating in the medical marijuana program. Currently, there 36 qualifying conditions for adult patients and ten qualifying conditions for patients under the age of 18.

There are 15 medical marijuana dispensaries and four producers licensed to operate within the state. Three more dispensaries are in the process of being opened after they were issued with licenses.

The medical marijuana program was launched in 2012. At that time, there were only 11 qualifying conditions. These included cancer, glaucoma, and PTSD (post-traumatic stress disorder). The program has expanded over the years to include other conditions such as cystic fibrosis, cerebral palsy, muscular dystrophy, and other terminal illnesses that require end of life care.

The legislators approved Medical marijuana for minors in 2016, and their qualifying conditions included severe epilepsy and uncontrolled intractable seizure disorder.

The state approval process is still ongoing for the additional qualifying conditions so it is expected that as more information becomes available regarding other conditions which can be managed using medical marijuana, the responsible body will receive testimony on the same and add those conditions without having to involve the lawmakers.

This approach of modifying the list of qualifying conditions without the seeking approval from lawmakers I a good one because it saves a lot of time and sidesteps partisan politics which can at times derail otherwise good programs.

One is led to imagine that marijuana companies like The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) and VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) must be glad that the pool of patients who can benefit from medical marijuana in Connecticut has been widened.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Former FDA Boss Calls for Federal Regulation of Marijuana Markets

On Monday, Scott Gottlieb, the former Food and Drug Administration Commissioner, said that the federal government should be given the authority to regulate states’ marijuana programs.

In a CNBC appearance, Scott Gottlieb said that the increase in vaping related lung illnesses calls for the need of a federal regulatory system that would give the agencies power to enforce industry standards on all facets of the legal cannabis market such as the potency of THC and the proper methods of consumption.

Although the official was previously not clear on the extent of federal government involvement citing that the vaping problems are due to conflicts between the state and federal laws– he did not say which would be his preferred policy fix. However, last week in a Wall Street Journal editorial, he provided some clarification by saying that federal drug scheduling laws for marijuana should be reformed to offer limited regulations and promote more research on cannabis.

During a TV interview, Gottlieb said that enforcing marijuana prohibition is not politically practicable anymore and that Congress should approve a federal law that allows the enactment of appropriate supervision by the regulatory authorities.

Although he is not in support of the legalization of recreational marijuana and if possible he would like it to shut down completely, the reality of the situation is that many states have already legalized it; thus, any federal system formed would have to accommodate recreational cannabis.

When he was asked if all the states would be in a position to implement all the regulations he has proposed, Gottlieb said no, because some states do not have the capacity nor the resources to control what is being sold in their legal dispensaries as well as shutting down the black market.

He said that for this to be possible, federal authorities are a necessity.

The regulatory model Gottlieb is envisioning is one where the FDA and agencies such as the Drug Enforcement Administration could control the potency of the products, the manufacturing process, the ingredients, and the purpose for which the products are made.

Gottlieb further added that by federalizing marijuana and allowing recreational consumption, they would be in a position where they can limit the types of cannabis products being sold, their potency, and the forms in which it can be consumed. However, he still thinks vaping products should be banned.

He said that the federal agencies should enact strict measures on medical cannabis while holding them to a higher standard and allowing recreational use of the product with lower concentrations of THC, which poses less harm that vaping e-liquids.

He concludes by saying that compromising is right where you allow some form of recreational consumption of marijuana, which is in low concentration in the states allowing it instead of leaving it as it is today where there are no federal laws governing marijuana in those state-legal markets.

Industry analysts believe that companies like VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) and The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) could be seeing lots of sense in the proposals of the former FDA chief.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) Reaffirms Timing of First Harvest at Kimmetts, Unveils 2020 Cultivation Plans

VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) this morning announced its expected commencement of the first harvest at its Kimmetts facility in Napanee, Ontario in the fourth quarter of 2019. In addition, VIVO unveiled its plans for the facility in 2020, which include an accelerated planting schedule and the contemplated use of five additional acres of land adjacent to the existing airhouses. VIVO made the announcements during its analyst and investor day held in Napanee, where the company showcased its airhouse technology, extraction programs and progress toward achieving EU GMP certification. “The fact that we expect to be able to commence first harvest within our stated timelines and budget speaks to the early success of the airhouses and the talent of our Napanee team,” VIVO CEO Barry Fishman said in the news release. “Kimmetts is expected to play a significant role in our strategy of bringing new value-added products to market, as well as contributing to our existing collection of premium brands, including Beacon Medical(TM), Fireside(TM), Canna Farms(TM) and Lumina(TM).”

To view the full press release, visit http://cnw.fm/g2Y6y

About VIVO Cannabis(TM)

VIVO, based in Napanee, Ontario, is recognized for trusted, high-quality products and services. It holds production and sales licenses from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical(TM), FIRESIDE(TM), Canna Farms(TM) and Lumina(TM). In August 2018, VIVO acquired Canna Farms, a premium cannabis company based in Hope, British Columbia. Canna Farms was B.C.’s first Licensed Producer and has several years of craft cultivation experience and expertise, as well as a significant patient base and positive cash flow. The company is significantly expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, including Germany and Australia. VIVO also operates Harvest Medicine, a patient-centric and highly scalable network of specialty medical cannabis clinics as well as a free telemedicine service. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally. For more information, visit the company’s website at www.VivoCannabis.com.

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://cnw.fm/VIVO

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Marijuana Legalization Bill Introduced in Pennsylvania

Just a few days after Gov. Tom Wolf (D) announced that he was now in support of legalizing recreational marijuana, a bill has been filed in the state Assembly seeking to create a state-run system through which recreational marijuana can be brought to the state.

Under the legislation introduced by Rep. David Delloso (D), adults 21 or older can possess, consume, purchase and even cultivate marijuana through a stores system run by the state through the Liquor Control Commission.

The text of this proposed law states that the legalization of marijuana is being sought in order to enhance the best use of law enforcement resources, promote personal freedom and avail more revenue in the state purse.

The proposal also includes suggested tax rates for recreational marijuana products. The 19 percent tax collected on sales would be put in the general fund of the state, and a separate regulatory program would be established to oversee industrial hemp.

One notable provision of this draft law seeks to create an avenue through which Pennsylvania would import recreational marijuana products from other states or even countries. However, the existing federal law regards marijuana as a controlled substance that cannot be moved across state lines, which is why companies that operate in different marijuana markets in the U.S. build entirely new systems instead of moving products from one state where they operate to another.

The import provision also creates a condition that other states or countries must meet if they are to engage in recreational marijuana trade with Pennsylvania; those jurisdictions must accept marijuana exports from Pennsylvania.

Oregon was the first to pass such a law providing for interstate commerce in marijuana, but their law had a provision that this mechanism could only be triggered once the federal government changed its laws on marijuana.

In June, Rep. Earl Blumenauer and Sen. Ron Wyden, both Democrats from Oregon, filed similar bills in Congress and the U.S. Senate respectively that would make it possible for states where marijuana is legal to trade in the substance with each other. However, these bills have never been scheduled for hearing.

If this bill is passed, the Liquor Control Commission would be given up to July 1 next year to have regulations ready for the implementation of the recreational marijuana program.

It isn’t yet clear how much support this proposal to run the marijuana program using a state cultivation and distribution model would work since it could put state employees directly in conflict with the federal government that would regard them as “drug traffickers.”

Experts are of the view that industry actors like VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) and VPR Brands LP (OTCQB: VPRB) will be watching to see whether Pennsylvania becomes the first state to run a recreational marijuana system.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Canadian Company to Offer First Odorless Marijuana

Are you tired of the strong smell of marijuana? A Canadian company may have the solution you have been looking for if their license application is approved by Health Canada, the regulator of the marijuana industry in the country.

CannabCo Pharmaceuticals, an Ontario-based company, announced last Tuesday that it would launch its odorless marijuana, and the company boasts that it is the first in the world to offer such a product.

CannabCo Pharmaceuticals intends to use a technology that it has named PURECANN to create this odorless marijuana. The company adds that it has exclusive rights to use this technology in Canada.

The PURECANN technology was originally developed for use in the medical marijuana industry in order to eliminate the characteristic harshness associated with smoking marijuana. The technology removes this harshness without affecting the potency of the substance.

The absence of the odor and the harshness makes this new form of marijuana more appealing to beginners who often break out into coughing fits when they try smoking cannabis for the first time.

While the company hasn’t provided any details about how the odorless marijuana will be used, they pointed out that consumers will not have to buy any third-party products or accessories. All that they need is the odorless marijuana.

The first reaction of the people who heard about this odorless marijuana was to say that they are curious to find out what effect removing the odor will have on the potency of the marijuana. Others said that the odor of marijuana is a good indicator of its potency, so it would be interesting to find out what it would be like to smoke that odorless cannabis.

Perhaps the real question now is whether there is a sustainable market for this odorless marijuana. CannabCo Pharmaceuticals is looking at the market of people who hate the smell of marijuana, and this could be a profitable niche whose needs haven’t been addressed by the existing products on the market.

The company is also looking at people who find themselves in environments where the smell of cannabis would be an issue. For example, the smell of cannabis can be a flashpoint if one lives in an apartment block and the smell from his or her joint drifts to nearby units whose occupants are opposed to using marijuana.

Additionally, people who do work that isn’t safety-sensitive and wish to smoke a joint during their lunch break can also benefit from this odorless marijuana since they wouldn’t have to worry that the smell would cling to their clothes and skin.

It would be interesting to know whether industry players like VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) and VPR Brands LP (OTCQB: VPRB) ever imagined that marijuana products would evolve to such an extent that companies now want to offer marijuana without the signature marijuana smell.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) Announces Partnership with Linneo Health to Supply Medical Cannabis in Europe

VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) this morning announced that it has engaged with Linneo Health S.L., a subsidiary of Alcaliber S.A., to be its European medical cannabis supply partner. A European leader in the pharmaceutical cannabis industry, Linneo Health recently received its EU-GMP (“Good Manufacturing Practices”) certification from the Spanish regulatory authorities. According to the update, the multi-year agreement includes increasing supply volumes as VIVO expands in the European medical market. “Our partnership with Linneo Health is part of our strategic priority to accelerate international market growth,” VIVO CEO Barry Fishman said in the news release. “We are excited to have an EU-GMP certified source of medical cannabis located within Europe. Through this partnership, we expect to be able to supply the European high-growth market with premium medical cannabis products and services. Our European based supply will allow VIVO to contribute to addressing the unmet medical needs of patients in Germany, which is one of our key target markets for international expansion.”

To view the full press release, visit http://cnw.fm/GyH9P

About VIVO Cannabis(TM)

VIVO, based in Napanee, Ontario, is recognized for trusted, high-quality products and services. It holds production and sales licenses from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical(TM), FIRESIDE(TM), Canna Farms(TM) and Lumina(TM). In August 2018, VIVO acquired Canna Farms, a premium cannabis company based in Hope, British Columbia. Canna Farms was B.C.’s first Licensed Producer and has several years of craft cultivation experience and expertise, as well as a significant patient base and positive cash flow. The company is significantly expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, including Germany and Australia. VIVO also operates Harvest Medicine, a patient-centric and highly scalable network of specialty medical cannabis clinics as well as a free telemedicine service. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally. For more information, visit the company’s website at www.VivoCannabis.com.

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://cnw.fm/VIVO

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Advocates Intensify Fight for Workers’ Right to Use Marijuana

Should someone using marijuana in a state where it is legal fear that they will lose their job or have their job application rejected? Pro-marijuana advocates are starting to show that the answer is an emphatic “no” and they are demanding for action in this regard.

It is ironical that California, which paved the way for recreational marijuana across the country, doesn’t have protections for workers who use legal marijuana within its state borders. Courts have ruled that the laws legalizing marijuana don’t shield workers from being fired for using marijuana and the attempt of lawmakers to correct this situation was vetoed by Gov. Schwarzenegger during his term in office.

However, things aren’t all bleak across the country. For starters, 15 states, including Arizona, Illinois, New Jersey, Pennsylvania and Rhode Island have all passed laws banning discriminating against job applicants or employees on the basis of their use of marijuana.

Nevada was the first to take this significant step after the state passed the law in June and Gov. Sisolak signed the bill. This law will take effect in 2020.

In April, the New York City Council approved a measure that bans pre-employment marijuana testing. This action shows that local authorities are ready to take the lead on this important matter if state legislatures take long to act on issues that the people find important.

In the past, the courts of law have largely upheld the right of employers to fire an employee for using marijuana or refuse to hire one who tests positive for the drug. However, this tide seems to be changing as well because many courts have ruled in favor of protecting the workers’ right to use marijuana in states where such use is legal.

For example, the right of employees to use medical marijuana in Massachusetts was upheld by a state court last year. Similar rulings were made in Connecticut and Rhode Island.

This year, federal courts also moved to protect this right when a federal court in Arizona ruled that a Walmart employee was wrongfully terminated on the basis of her use of medical marijuana.

The winds or change also seem to be reaching Capitol Hill as a bill was introduced in Congress seeking to protect federal workers from having their employment status determined solely on the basis that such employees use marijuana in states where it is legal.

Industry watchers are convinced that entities like TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) and VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) are pleased by the push to protect workers who use marijuana legally since this will lift a cloud from a huge number of people who feared to use legal marijuana for fear that their jobs or employability will be placed in jeopardy.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) Posts Q2 2019 Financial and Operating Results

VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF) on Wednesday announced financial and operating results for the second quarter 2019. Among other highlights, the company reported net revenue of $5.3 million in the quarter, representing a five-fold increase from the same period last year. The company’s senior management will be hosting a conference call to discuss the results today, August 29 at 10:00 AM ET. To join the call, dial 647-427-7450 or 1-888-231-8191 using the conference ID 4479716. “The progress our team has made on all four of our strategic priorities positions us well for future growth,” VIVO CEO Barry Fishman stated in the news release. “We remain focused on increasing long-term shareholder value by continuing to establish ourselves as a premium provider of cannabis products and services. Our positive momentum is expected to lead to increased revenue generation and product breadth in the second half of the year.”

To join the live webcast, visit http://cnw.fm/FmWp8

To view the full press release visit http://cnw.fm/Cxg0R

About VIVO Cannabis(TM)

VIVO, based in Napanee, Ontario, is recognized for trusted, premium cannabis products and services. It holds production and sales licenses from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology at its Canna Farms facility in Hope, B.C., and at its Vanluven facility in Napanee, Ontario. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical(TM), Fireside(TM), Canna Farms(TM) and Lumina(TM). The Company is significantly expanding its production capacity and distribution channels; growing its domestic medical cannabis platform, including Harvest Medicine, its patient-centric, highly scalable network of specialty medical cannabis clinics and services; promoting production and cultivation innovation and pursuing partnership and product development opportunities; and actively focusing on growth in select international markets, including Germany and Australia. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally. For more information, visit the company’s website at www.VivoCannabis.com.

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://cnw.fm/VIVO

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Thai State Hospitals Start Distributing Marijuana Oils

Thai state hospitals have stocked up on cannabis oils and are ready to start dispensing them to patients, according to a press release by Anutin Chanvirakul, the Public Health Minister who also doubles as the Deputy Prime Minister of Thailand.

Chanvirakul revealed that Thai state hospitals received a total of 4,500 bottles of marijuana extracts starting on August 7 as a result of the law which was passed in December to make medical cannabis legal in the Asian country.

Under this new law, the government will be responsible for regulating the production, processing and sale of medical marijuana products. Companies will have to apply and be granted licenses before they engage in any activity connected to this new medical marijuana industry.

The Government Pharmaceutical Organization (GPO), an agency run by the Thai government, will work with other state agencies to avail a total of 200,000 bottles of marijuana oil on a monthly basis starting in the month of September. To meet this requirement, the GPO intends to start growing marijuana in greenhouses next year so that supply shortages don’t jeopardize the implementation of the medical marijuana program.

The marijuana oils being stockpiled in state-run hospitals will be given out free of charge to the qualifying patients who are enrolled in the state’s universal health care scheme (the Gold Card) or any of the other health insurance schemes available in the country.

Thai doctors will first diagnose each patient and then recommend the particular cannabis oil formulation that is best suited to help that patient. Based on this prescription, the hospital pharmacy will dispense the oil to be used by the patient.

The addition of medical marijuana to Thai law is widely seen as a boost to the agricultural sector of the country since its favorable conditions can position Thailand as a leader in marijuana production in the region and internationally.

Prohibition Partners, a marijuana research company, estimates that the marijuana industry in Thailand could be worth at least $661 million by 2024.

However, this potential can only be turned into reality when marijuana cultivation and processing is ramped up quickly enough to meet the expected high demand among patients in the country with a 300-year history of using marijuana as a medicine before the drug was outlawed in the 1930s.

The country hopes to develop its own cannabis strains that will compete favorably on the world marijuana market. Laos, Malaysia and the Philippines are currently considering to legalize marijuana for medicinal purposes.

Experts welcome the bold step taken by this Asian country to embrace medical marijuana and they believe that industry participants like VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) and VPR Brands LP (OTCQB: VPRB) may be thrilled that the Asian medical marijuana market could soon open up.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com